Real-World Thyrotropin Suppression Practices for Low-Risk Papillary Thyroid Cancer Exceed Guideline Recommendations

Clinical ThyroidologyVol. 33, No. 10 Thyroid CancerReal-World Thyrotropin Suppression Practices for Low-Risk Papillary Thyroid Cancer Exceed Guideline RecommendationsBenjamin J. GigliottiBenjamin J. GigliottiDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York, U.S.A.Search for more papers by this authorPublished Online:7 Oct 2021https://doi.org/10.1089/ct.2021;33.441-443AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 33Issue 10Oct 2021 InformationCopyright 2021, Mary Ann Liebert, Inc.To cite this article:Benjamin J. Gigliotti.Real-World Thyrotropin Suppression Practices for Low-Risk Papillary Thyroid Cancer Exceed Guideline Recommendations.Clinical Thyroidology.Oct 2021.441-443.http://doi.org/10.1089/ct.2021;33.441-443Published in Volume: 33 Issue 10: October 7, 2021PDF download